Home

STONEPINE CAPITAL, L.P.

CIK 1370042 · last filed 2021-08-09

STONEPINE CAPITAL, L.P. is a corporate insider who has filed 16 SEC Form 4 insider transactions across 3 companies since 2015. Across all open-market trades the lifetime net is +$2.7M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $155.5M across reported positions. The firm reports its address in Bend, OR. 10 SEC filings were submitted jointly with QLT INC/BC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$155.53M

Companies

3

Total Filings

16

Lifetime Open-Market Net

$2.71M

Filer Profile

Reported Address
2900 NW CLEARWATER DRIVE
SUITE 100-11
BEND, OR 97703
Phone
(541) 647-5673
State of Incorporation
DE
Formerly Known As
STONEPINE CAPITAL L P (2006–2015)
Related Filers
QLT INC/BC — 10 joint filings, latest 2019-12-12
TIMOTHY P LYNCH — 2 joint filings, latest 2017-03-21
Jon M Plexico — 2 joint filings, latest 2017-03-21
Stonepine Capital Management, LLC — 2 joint filings, latest 2017-03-21
Recro Pharma, Inc. — 1 joint filings, latest 2016-07-21
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Apollo Endosurgery, Inc. (APEN) Delisted 10%+ Owner 1,580,518 $10.00 $15.81M $499.8K 8 2019-08-14
QLTI 10%+ Owner 5,763,568 $26.98 $155.53M $206.6K 1 2016-09-15
VIVEVE MEDICAL, INC. (TCON) Delisted 10%+ Owner 91,988 $0.03 $3.0K $2.00M 1 2015-11-25

Recent Filings

16 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2021-08-09 — Disp (D) −6,770,000 $0
2019-12-12 — Buy (P) +6,242 $4.3K
2019-12-09 — Buy (P) +9,700 $6.8K
2019-11-26 — Buy (P) +89,845 $67.0K
2019-10-16 — Buy (P) +100,000 $64.9K
2019-08-14 Apollo Endosurgery, Inc. (APEN) Delisted Mixed −1,000,000 $0 EDGAR
2018-12-31 Apollo Endosurgery, Inc. (APEN) Delisted Sell (S) −250,000 -$750.0K EDGAR
2018-12-28 Apollo Endosurgery, Inc. (APEN) Delisted Sell (S) −500,000 -$1.50M EDGAR
2018-11-21 Apollo Endosurgery, Inc. (APEN) Delisted Buy (P) +57,430 $195.9K EDGAR
2018-11-06 Apollo Endosurgery, Inc. (APEN) Delisted Buy (P) +300,000 $1.50M EDGAR
Showing 1–10 of 16
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.